Womb with a fix: Scientists eye CRISPR to zap rare diseases before babies are born
Scientists are developing ways to use CRISPR gene editing to treat rare genetic diseases in babies before birth, aiming to prevent irreversible damage. Researchers found the editing tools reach the heart and muscles of unborn animals more easily than after birth, which could help with conditions like Duchenne muscular dystrophy. Advances in prenatal testing and in delivering CRISPR via lipid nanoparticles are speeding progress. Getting past the blood-brain barrier remains hard, and human trials are still at least three years away.
Why it matters: It points to a possible future in which some severe genetic diseases are treated before birth to prevent irreversible damage, affecting families with rare conditions, though human trials remain at least three years away.
Comments
No comments yet.